Keurig Dr Pepper Inc. (NASDAQ:KDP) Receives $36.62 Consensus Price Target from Brokerages

Shares of Keurig Dr Pepper Inc. (NASDAQ:KDP) have earned a consensus rating of “Moderate Buy” from the fourteen research firms that are presently covering the company, MarketBeat reports. Six investment analysts have rated the stock with a hold recommendation and eight have given a buy recommendation to the company. The average 12-month price objective among brokerages that have issued ratings on the stock in the last year is $36.57.

Several equities analysts have recently weighed in on KDP shares. Jefferies Financial Group reduced their price objective on Keurig Dr Pepper from $37.00 to $35.00 and set a “buy” rating on the stock in a research note on Wednesday, March 27th. Barclays upped their price target on Keurig Dr Pepper from $36.00 to $38.00 and gave the stock an “overweight” rating in a report on Monday, April 29th. UBS Group upped their price target on Keurig Dr Pepper from $39.00 to $40.00 and gave the stock a “buy” rating in a report on Monday, June 10th. TD Cowen upped their price target on Keurig Dr Pepper from $32.00 to $35.00 and gave the stock a “hold” rating in a report on Friday, April 26th. Finally, BNP Paribas assumed coverage on Keurig Dr Pepper in a report on Monday. They issued a “neutral” rating and a $36.00 price target for the company.

Keurig Dr Pepper Trading Down 0.1 %

Keurig Dr Pepper stock opened at $34.36 on Monday. The stock has a 50-day moving average price of $33.83 and a 200 day moving average price of $32.08. The company has a current ratio of 0.51, a quick ratio of 0.34 and a debt-to-equity ratio of 0.52. Keurig Dr Pepper has a 52 week low of $27.66 and a 52 week high of $35.00. The stock has a market cap of $46.58 billion, a PE ratio of 22.17, a P/E/G ratio of 2.60 and a beta of 0.61.

Keurig Dr Pepper (NASDAQ:KDP) last issued its quarterly earnings results on Thursday, April 25th. The company reported $0.38 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.34 by $0.04. Keurig Dr Pepper had a return on equity of 10.18% and a net margin of 14.52%. The firm had revenue of $3.47 billion for the quarter, compared to analyst estimates of $3.41 billion. During the same period last year, the company earned $0.34 EPS. The firm’s quarterly revenue was up 3.4% on a year-over-year basis. Equities research analysts predict that Keurig Dr Pepper will post 1.92 earnings per share for the current fiscal year.

Keurig Dr Pepper Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, July 12th. Stockholders of record on Friday, June 28th will be paid a $0.215 dividend. The ex-dividend date of this dividend is Friday, June 28th. This represents a $0.86 annualized dividend and a dividend yield of 2.50%. Keurig Dr Pepper’s payout ratio is 55.48%.

Insider Transactions at Keurig Dr Pepper

In other news, insider Matthew Andrew Archambault sold 8,000 shares of the stock in a transaction on Thursday, May 23rd. The stock was sold at an average price of $34.19, for a total value of $273,520.00. Following the completion of the transaction, the insider now owns 12,565 shares of the company’s stock, valued at $429,597.35. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. In related news, VP Angela A. Stephens sold 25,000 shares of the firm’s stock in a transaction dated Tuesday, April 30th. The stock was sold at an average price of $33.61, for a total transaction of $840,250.00. Following the completion of the transaction, the vice president now owns 76,081 shares of the company’s stock, valued at $2,557,082.41. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, insider Matthew Andrew Archambault sold 8,000 shares of the firm’s stock in a transaction dated Thursday, May 23rd. The shares were sold at an average price of $34.19, for a total value of $273,520.00. Following the transaction, the insider now directly owns 12,565 shares of the company’s stock, valued at approximately $429,597.35. The disclosure for this sale can be found here. Over the last quarter, insiders sold 81,520 shares of company stock valued at $2,750,739. 1.00% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On Keurig Dr Pepper

Hedge funds have recently modified their holdings of the stock. EverSource Wealth Advisors LLC lifted its stake in Keurig Dr Pepper by 122.6% in the 1st quarter. EverSource Wealth Advisors LLC now owns 1,367 shares of the company’s stock worth $46,000 after acquiring an additional 753 shares in the last quarter. Cetera Advisors LLC lifted its stake in Keurig Dr Pepper by 823.3% in the 1st quarter. Cetera Advisors LLC now owns 101,758 shares of the company’s stock worth $3,121,000 after acquiring an additional 90,737 shares in the last quarter. Cetera Investment Advisers lifted its stake in Keurig Dr Pepper by 127.7% in the 1st quarter. Cetera Investment Advisers now owns 221,134 shares of the company’s stock worth $6,782,000 after acquiring an additional 124,022 shares in the last quarter. Swedbank AB purchased a new stake in Keurig Dr Pepper in the 1st quarter worth about $14,034,000. Finally, Sanibel Captiva Trust Company Inc. lifted its stake in Keurig Dr Pepper by 10.0% in the 1st quarter. Sanibel Captiva Trust Company Inc. now owns 384,466 shares of the company’s stock worth $11,792,000 after acquiring an additional 34,890 shares in the last quarter. 85.23% of the stock is owned by hedge funds and other institutional investors.

About Keurig Dr Pepper

Keurig Dr Pepper Inc owns, manufactures, and distributors beverages and single serve brewing systems in the United States and internationally. It operates through three segments: U.S. Refreshment Beverages, U.S. Coffee, and International. The U.S. Refreshment Beverages segment manufactures and distributes branded concentrates, syrup, and finished beverages.